Kenneth W. Zamkoff, MD
- Professor Emeritus, Cancer Medicine (Winston-Salem)

Kenneth W. Zamkoff, MD
- Professor Emeritus, Cancer Medicine (Winston-Salem)
- Positions
- Professor Emeritus, Cancer Medicine (Winston-Salem)
- Departments and Affiliations
- Cancer Medicine (Winston-Salem)
Research
- High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis. Gladstone DE, Zamkoff KW, Krupp L, Peyster R, Sibony P, Christodoulou C, Locher E, Coyle PK. Arch. Neurol. 2006 Oct; 63(10):1388-93.
- Granulocytic sarcoma presenting as bilateral adrenal masses. Singh BK, Aleyas S, Hu Y, Zamkoff KW, Gladstone DE. Am. J. Hematol. 2005 May; 79(1):73-5.
- Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil. Gladstone DE, Golightly MG, Zamkoff KW. Rheumatol. Int. 2005 Oct; 25(8):635-6.
- Use of fluorescence in situ hybridization to detect minimal residual disease in hematopoietic stem cell assays from peripheral blood stem cells of 2 patients with trisomy 8 acute myeloid leukemia. Dodge W, Cruz J, Zamkoff K, Hurd D, Pettenati MJ. Stem Cells Dev. 2004 Feb; 13(1):23-6.
- Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplant. Zamkoff KW, Bergman S, Beaty MW, Buss DH, Pettenati MJ, Hurd DD. Bone Marrow Transplant. 2003 Feb; 31(3):219-22.